Sarah Allford

Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias

Sarah Allford, Beverley J. Hunt, Peter Rose et al. · British Journal of Haematology · 2003 · 380 citations · Full text

von Willebrand factor-cleaving protease activity in congenital thrombotic thrombocytopenic purpura

Sarah Allford, Paul Harrison, Andrew Lawrie et al. · British Journal of Haematology · 2000 · 94 citations

Immunology, Pathology, Thrombosis +16

Mutation analysis and clinical implications of von Willebrand factor–cleaving protease deficiency

K. Assink, Rikke H.M. Schiphorst, Sarah Allford et al. · Kidney International · 2003 · 90 citations · Full text

Disease Mechanism, Genetic Disorder, Von Willebrand +9

Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARalpha rearrangement in newly diagnosed AML

Sarah Allford, David Grimwade, Stephen E. Langabeer et al. · British Journal of Haematology · 1999 · 38 citations

Molecular Screening, Pml/raralpha Rearrangements, Mixed-phenotype Acute Leukemia +18

Successful treatment of congenital thrombotic thrombocytopenic purpura using the intermediate purity factor VIII concentrate BPL 8Y

Will Lester, Michael D. Williams, Sarah Allford et al. · British Journal of Haematology · 2002 · 33 citations

Thrombopoiesis, Thrombosis, Severe Congenital Ttp +12